FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

89401004: Potassium guaiacolsulfonate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
148225015 Potassium guaiacolsulfonate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
508494017 Potassium guaiacolsulphonate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
832288017 Potassium guaiacolsulfonate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3464631000005115 kaliumguaiacolsulfonat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Potassium guaiacolsulfonate Is a ekspektorans false Inferred relationship Some
Potassium guaiacolsulfonate Is a Expectorant agent (substance) false Inferred relationship Some
Potassium guaiacolsulfonate Is a Organic compound false Inferred relationship Some
Potassium guaiacolsulfonate Is a Potassium compound true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
kaliumguaiacolsulfonat 75 mg/5 ml væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Potassium guaiacolsulfonate Inferred relationship Some
hydrocodonhydrogentartrat 5 mg + kaliumguaiacolsulfonat 300 mg væske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Potassium guaiacolsulfonate Inferred relationship Some
hydrocodonhydrogentartrat + kaliumguaiacolsulfonat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Potassium guaiacolsulfonate Inferred relationship Some
Product containing hydrocodone and potassium guaiacolsulfonate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Potassium guaiacolsulfonate Inferred relationship Some 2
Hydrocodone and potassium guaiacolsulfonate only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Potassium guaiacolsulfonate Inferred relationship Some 2

This concept is not in any reference sets

Back to Start